Patents by Inventor Jyunichi Kamizono

Jyunichi Kamizono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8709812
    Abstract: It is intended to provide a drug to be used in gene therapy which specifically targets abnormal cells such as tumor cells and destroys the same for healing. Namely, a drug comprising, as the active ingredient, a proliferative vector which contains a Survivin promoter proliferating depending on the expression of Survivin. The drug may be used in order to treat tumor. In this drug, use may be made of an adenovirus as the vector. In the adenovirus of this drug, an endogenous promoter of an E1A domain may be substituted with a Survivin promoter.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: April 29, 2014
    Inventors: Kenichiro Kosai, Jyunichi Kamizono, Satoshi Nagano
  • Publication number: 20120230954
    Abstract: It is intended to provide a drug to be used in gene therapy which specifically targets abnormal cells such as tumor cells and destroys the same for healing. Namely, a drug comprising, as the active ingredient, a proliferative vector which contains a Survivin promoter proliferating depending on the expression of Survivin. The drug may be used in order to treat tumor. In this drug, use may be made of an adenovirus as the vector. In the adenovirus of this drug, an endogenous promoter of an E1A domain may be substituted with a Survivin promoter.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 13, 2012
    Inventors: Kenichiro Kosai, Jyunichi Kamizono, Satoshi Nagano
  • Patent number: 8142770
    Abstract: It is intended to provide a drug to be used in gene therapy which specifically targets abnormal cells such as tumor cells and destroys the same for healing. Namely, a drug comprising, as the active ingredient, a proliferative vector which contains a Survivin promoter proliferating depending on the expression of Survivin. This drug may be used in order to treat tumor. In this drug, use may be made of an adenovirus as the vector. In the adenovirus of this drug, an endogenous promoter of an E1A domain may be substituted with a Survivin promoter.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: March 27, 2012
    Inventors: Jyunichi Kamizono, Satoshi Nagano, Kenichiro Kosai
  • Publication number: 20090181907
    Abstract: It is intended to provide a drug to be used in gene therapy which specifically targets abnormal cells such as tumor cells and destroys the same for healing. Namely, a drug comprising, as the active ingredient, a proliferative vector which contains a Survivin promoter proliferating depending on the expression of Survivin. This drug may be used in order to treat tumor. In this drug, use may be made of an adenovirus as the vector. In the adenovirus of this drug, an endogenous promoter of an E1A domain may be substituted with a Survivin promoter.
    Type: Application
    Filed: May 23, 2005
    Publication date: July 16, 2009
    Inventors: Jyunichi Kamizono, Satoshi Nagano, Kenichiro Kosai